1259 related articles for article (PubMed ID: 33522308)
1. Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19.
Bravaccini S; Fonzi E; Tebaldi M; Angeli D; Martinelli G; Nicolini F; Parrella P; Mazza M
Cell Transplant; 2021; 30():963689721991477. PubMed ID: 33522308
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
[TBL] [Abstract][Full Text] [Related]
3. Do Anti-androgens Have Potential as Therapeutics for COVID-19?
Mauvais-Jarvis F
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 34089595
[TBL] [Abstract][Full Text] [Related]
4. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
Front Immunol; 2022; 13():811430. PubMed ID: 35250984
[TBL] [Abstract][Full Text] [Related]
5. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
6. Androgen sensitivity gateway to COVID-19 disease severity.
Wambier CG; Goren A; Vaño-Galván S; Ramos PM; Ossimetha A; Nau G; Herrera S; McCoy J
Drug Dev Res; 2020 Nov; 81(7):771-776. PubMed ID: 32412125
[TBL] [Abstract][Full Text] [Related]
7. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
Gupta VK; Murthy MK; Patil S
Curr Drug Targets; 2021; 22(10):1149-1157. PubMed ID: 33243116
[TBL] [Abstract][Full Text] [Related]
8. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer.
Lykkesfeldt AE
Acta Oncol; 1996; 35 Suppl 5():9-14. PubMed ID: 9142958
[TBL] [Abstract][Full Text] [Related]
10. Novel drugs targeting the androgen receptor pathway in prostate cancer.
Mateo J; Smith A; Ong M; de Bono JS
Cancer Metastasis Rev; 2014 Sep; 33(2-3):567-79. PubMed ID: 24390422
[TBL] [Abstract][Full Text] [Related]
11. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Cochrane DR; Bernales S; Jacobsen BM; Cittelly DM; Howe EN; D'Amato NC; Spoelstra NS; Edgerton SM; Jean A; Guerrero J; Gómez F; Medicherla S; Alfaro IE; McCullagh E; Jedlicka P; Torkko KC; Thor AD; Elias AD; Protter AA; Richer JK
Breast Cancer Res; 2014 Jan; 16(1):R7. PubMed ID: 24451109
[TBL] [Abstract][Full Text] [Related]
12. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
Setlur SR; Mertz KD; Hoshida Y; Demichelis F; Lupien M; Perner S; Sboner A; Pawitan Y; Andrén O; Johnson LA; Tang J; Adami HO; Calza S; Chinnaiyan AM; Rhodes D; Tomlins S; Fall K; Mucci LA; Kantoff PW; Stampfer MJ; Andersson SO; Varenhorst E; Johansson JE; Brown M; Golub TR; Rubin MA
J Natl Cancer Inst; 2008 Jun; 100(11):815-25. PubMed ID: 18505969
[TBL] [Abstract][Full Text] [Related]
14. Targeted androgen pathway suppression in localized prostate cancer: a pilot study.
Mostaghel EA; Nelson PS; Lange P; Lin DW; Taplin ME; Balk S; Ellis W; Kantoff P; Marck B; Tamae D; Matsumoto AM; True LD; Vessella R; Penning T; Hunter Merrill R; Gulati R; Montgomery B
J Clin Oncol; 2014 Jan; 32(3):229-37. PubMed ID: 24323034
[TBL] [Abstract][Full Text] [Related]
15. Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer.
Kulkoyluoglu E; Madak-Erdogan Z
Steroids; 2016 Oct; 114():41-47. PubMed ID: 27394959
[TBL] [Abstract][Full Text] [Related]
16. Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes.
Baratchian M; McManus JM; Berk MP; Nakamura F; Mukhopadhyay S; Xu W; Erzurum S; Drazba J; Peterson J; Klein EA; Gaston B; Sharifi N
Sci Rep; 2021 May; 11(1):11130. PubMed ID: 34045511
[TBL] [Abstract][Full Text] [Related]
17. Roles of steroid receptors in the lung and COVID-19.
Leach DA; Brooke GN; Bevan CL
Essays Biochem; 2021 Dec; 65(6):1025-1038. PubMed ID: 34328182
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen ("Nolvadex"): a review.
Clemons M; Danson S; Howell A
Cancer Treat Rev; 2002 Aug; 28(4):165-80. PubMed ID: 12363457
[TBL] [Abstract][Full Text] [Related]
19. Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directions.
Isaacsson Velho P; Carducci MA
Expert Opin Investig Drugs; 2018 Oct; 27(10):811-822. PubMed ID: 30118330
[TBL] [Abstract][Full Text] [Related]
20. Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review.
Kono M; Fujii T; Lim B; Karuturi MS; Tripathy D; Ueno NT
JAMA Oncol; 2017 Sep; 3(9):1266-1273. PubMed ID: 28301631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
